Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study

J Trop Pediatr. 2004 Dec;50(6):354-6. doi: 10.1093/tropej/50.6.354.

Abstract

Little is known about clinical and epidemiological features of Plesiomonas shigelloides-associated diarrhoea in children. We reviewed hospital-based surveillance records of 38 children with diarrhoea having P. shigelloides as the only pathogen isolated from their faecal specimen. Of those 38 children, 29 (76 per cent) were below 2 years of age and 28 (74 per cent) were male. Thirty-two (84 per cent) children presented with watery diarrhoea and six (16 per cent) had dysenteric stools. Vomiting was a feature in 27 (71 per cent) children and clinically significant dehydration was observed in nine (23 per cent) children. Fever was present in three (8 per cent) children and five (13 per cent) had diarrhoea 14 days. Thirty-three (87 per cent) children were successfully treated with ORS alone and only five (13 per cent) required intravenous fluid in addition to ORS. Plesiomonas shigelloides was isolated throughout the year. The findings may be of public health importance for creating awareness among physicians about the clinical profile and management strategy of P. shigelloides-associated diarrhoea in children.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Age Distribution
  • Anti-Infective Agents / therapeutic use
  • Bangladesh / epidemiology
  • Child, Preschool
  • Cohort Studies
  • Combined Modality Therapy
  • Developing Countries
  • Diarrhea, Infantile / epidemiology*
  • Diarrhea, Infantile / microbiology*
  • Female
  • Fluid Therapy / methods
  • Gram-Negative Bacterial Infections / diagnosis
  • Gram-Negative Bacterial Infections / epidemiology*
  • Gram-Negative Bacterial Infections / therapy
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Plesiomonas / isolation & purification*
  • Prognosis
  • Prospective Studies
  • Public Health
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution

Substances

  • Anti-Infective Agents